Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.

Publication Type:

Journal Article

Source:

Antiviral therapy, Volume 13, Issue 6, p.799-807 (2008)

Keywords:

2008, Adult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Female, HIV Infections, HIV Seropositivity, HIV-1, Human Biology Division, Humans, Infant, Newborn, Infectious Disease Transmission, Vertical, Lamivudine, Milk, Human, Nevirapine, PREGNANCY, Pregnancy Complications, Infectious, Public Health Sciences Division, RNA, Viral, Treatment Outcome, Zidovudine

Abstract:

Defining the effect of antiretroviral regimens on breast milk HIV type-1 (HIV-1) levels is useful to inform the rational design of strategies to decrease perinatal HIV-1 transmission.